Literature DB >> 33377614

Spatial and dosimetric evaluation of residual distortions of prostate and seminal vesicle bed after image-guided definitive and postoperative radiotherapy of prostate cancer with endorectal balloon.

Sabine Levegrün1, Christoph Pöttgen1, Konstantinos Xydis1, Maja Guberina1, Jehad Abu Jawad1, Martin Stuschke1.   

Abstract

PURPOSE: To quantify daily residual deviations from the planned geometry after image-guided prostate radiotherapy with endorectal balloon and to evaluate their effect on the delivered dose distribution.
METHODS: Daily kV-CBCT imaging was used for online setup-correction in six degrees of freedom (6-dof) for 24 patients receiving definitive (12 RTdef patients) or postoperative (12 RTpostop patients) radiotherapy with endorectal balloon (overall 739 CBCTs). Residual deviations were evaluated using several spatial and dosimetric variables, including: (a) posterior Hausdorff distance HDpost (=maximum distance between planned and daily CTV contour), (b) point Pworst with largest HDpost over all fractions, (c) equivalent uniform dose using a cell survival model (EUDSF ) and the generalized EUD concept (gEUDa with parameter a = -7 and a = -20). EUD values were determined for planned ( EUD SF plan ), daily ( EUD SF ind ), and delivered dose distributions ( EUD SF accum ) for plans with 6 mm (=clinical plans) and 2 mm CTV-to-PTV margin. Time series analyses of interfractional spatial and dosimetric deviations were conducted.
RESULTS: Large HDpost values ≥ 12.5 mm (≥15 mm) were observed in 20/739 (5/739) fractions distributed across 7 (3) patients. Points Pworst were predominantly located at the posterior CTV boundary in the seminal vesicle region (16/24 patients, 6/7 patients with HDpost  ≥ 12.5 mm). Time series analyses revealed a stationary white noise characteristic of HDpost and relative dose at Pworst . The EUDSF difference between planned and accumulated dose distributions was < 5.4% for all 6-mm plans. Evaluating 2-mm plans, EUDSF deteriorated by < 10% (<5%) in 75% (58.5%) of the patients. EUD SF accum was well described by the median value of the EUD SF ind distribution. PTV margin calculation at Pworst yielded 8.8 mm.
CONCLUSIONS: Accumulated dose distributions in prostate radiotherapy with endorectal balloon are forgiving of considerable residual distortions after 6-dof patient setup if they are observed in a minority of fractions and the median value of EUD SF ind determined per fraction stays within 95% of prescribed dose. Common PTV margin calculations are overly conservative because after online correction of translational and rotational errors only residual deformations need to be included. These results provide guidelines regarding online navigation, margin optimization, and treatment adaptation strategies.
© 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.

Entities:  

Keywords:  accumulated dose distributions; image-guided radiotherapy; prostate cancer; residual distortions; time series

Mesh:

Year:  2020        PMID: 33377614      PMCID: PMC7856505          DOI: 10.1002/acm2.13138

Source DB:  PubMed          Journal:  J Appl Clin Med Phys        ISSN: 1526-9914            Impact factor:   2.102


  38 in total

1.  Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning.

Authors:  Jan Unkelbach; Thomas Bortfeld; Benjamin C Martin; Martin Soukup
Journal:  Med Phys       Date:  2009-01       Impact factor: 4.071

2.  Effect of endorectal balloon positioning errors on target deformation and dosimetric quality during prostate SBRT.

Authors:  Bernard L Jones; Gregory Gan; Brian Kavanagh; Moyed Miften
Journal:  Phys Med Biol       Date:  2013-10-30       Impact factor: 3.609

3.  Use of image registration and fusion algorithms and techniques in radiotherapy: Report of the AAPM Radiation Therapy Committee Task Group No. 132.

Authors:  Kristy K Brock; Sasa Mutic; Todd R McNutt; Hua Li; Marc L Kessler
Journal:  Med Phys       Date:  2017-05-23       Impact factor: 4.071

4.  Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.

Authors:  Michel Ghilezan; Di Yan; Jian Liang; David Jaffray; John Wong; Alvaro Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

5.  Local Protocol Variations for Image Guided Radiation Therapy in the Multicenter Dutch Hypofractionation (HYPRO) Trial: Impact of Rectal Balloon and MRI Delineation on Anorectal Dose and Gastrointestinal Toxicity Levels.

Authors:  Ruud C Wortel; Wilma D Heemsbergen; Robert Jan Smeenk; Marnix G Witte; Stijn D G Krol; Floris J Pos; Luca Incrocci
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-08-03       Impact factor: 7.038

6.  Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy.

Authors:  Emile N J Th van Lin; Jón Kristinsson; Mariëlle E P Philippens; Dirk J de Jong; Lisette P van der Vight; Johannes H A M Kaanders; Jan Willem Leer; Andries G Visser
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-08       Impact factor: 7.038

7.  What CTV-to-PTV margins should be applied for prostate irradiation? Four-dimensional quantitative assessment using model-based deformable image registration techniques.

Authors:  Gert J Meijer; Jeroen de Klerk; Karl Bzdusek; Hetty A van den Berg; Rogier Janssen; Michael R Kaus; Patrick Rodrigus; Peter-Paul van der Toorn
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-24       Impact factor: 7.038

8.  Set-up errors due to endorectal balloon positioning in intensity modulated radiation therapy for prostate cancer.

Authors:  Chun-Wei Wang; Fok-Ching Chong; Ming-Kuen Lai; Yeong-Shiau Pu; Jian-Kuen Wu; Jason Chia-Hsien Cheng
Journal:  Radiother Oncol       Date:  2007-08-13       Impact factor: 6.280

Review 9.  Clinical implications of heterogeneity of tumor response to radiation therapy.

Authors:  H Suit; S Skates; A Taghian; P Okunieff; J T Efird
Journal:  Radiother Oncol       Date:  1992-12       Impact factor: 6.280

10.  Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers.

Authors:  Gerard J van der Wielen; Theodore F Mutanga; Luca Incrocci; Wim J Kirkels; Eliana M Vasquez Osorio; Mischa S Hoogeman; Ben J M Heijmen; Hans C J de Boer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.